NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Wen, Sara Witting Christensen; Nederby, Line; Andersen, Rikke Fredslund; Hansen, Torben Schjødt; Nyhus, Christa Haugaard; Hilberg, Ole; Jakobsen, Anders; Hansen, Torben Frøstrup

Wen, Sara Witting Christensen; Nederby, Line; Andersen, Rikke Fredslund; Hansen, Torben Schjødt; Nyhus, Christa Haugaard; Hilberg, Ole; Jakobsen, Anders; Hansen, Torben Frøstrup.

Afiliación

Wen SWC; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark. sara.witting.christensen.wen@rsyd.dk.
Nederby L; Department of Regional Health Research, University of Southern Denmark, J.B. Winsloews Vej 19, 3rd floor, 5000, Odense C, Denmark. sara.witting.christensen.wen@rsyd.dk.
Andersen RF; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Hansen TS; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Nyhus CH; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Hilberg O; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Jakobsen A; Department of Regional Health Research, University of Southern Denmark, J.B. Winsloews Vej 19, 3rd floor, 5000, Odense C, Denmark.
Hansen TF; Department of Medicine, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.

Br J Cancer ; 129(1): 135-142, 2023 07.

Article en En | MEDLINE | ID: mdl-37137997

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Humanos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/patología; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patología; Inhibidores de Puntos de Control Inmunológico/farmacología; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Receptor de Muerte Celular Programada 1; Pronóstico; Interferón gamma; Células Asesinas Naturales/metabolismo; Biomarcadores de Tumor/genética; Antígeno B7-H1/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google